President Trump announces a new round of drug-pricing agreements with international pharmaceutical companies and some smaller biotechs, part of a push to make healthcare more affordable for Americans. ↧ Trump announces new drug-pricing deals with 9 pharma companies The deals will build on agreements the administration struck with 17 of the world’s largest drugmakers, including Pfizer, Eli Lilly and Amgen, starting last year.